Evidence map›Paper›PMID 41772178›Full record

ArticleNPJ digital medicine2026

A test-time clinically adaptive framework for detecting multiple fundus diseases harnessing ophthalmic foundation models.

Hongyang Jiang, Zirong Liu, Mengdi Gao, Bowen Xu, Danqi Fang, Chunwen Zheng, Ruyue Shen, Truong X Nguyen, An Ran Ran, Clement C Tham and 3 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hongyang Jiang *Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China. hongyangjiang@cuhk.edu.hk.
Zirong Liu *School of Ophthalmology and Optometry and Eye Hospital, Wenzhou Medical University, Wenzhou, China.
Mengdi Gao *College of Chemistry and Life Science, Beijing University of Technology, Beijing, China.
Bowen XuDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Danqi FangDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Chunwen ZhengDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Ruyue ShenDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Truong X NguyenDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
An Ran RanDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Clement C ThamDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Qinghua HeDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Simon K H SzetoDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Carol Y CheungDepartment of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China. carolcheung@cuhk.edu.hk.

Funding

Chinese University of Hong Kong Direct Grant Ref. 2025.128
6 · The paper itself

Abstract

Fundus diseases are leading causes of global vision impairment, often presenting with complex comorbidities that challenge conventional artificial intelligence models. While ophthalmic foundation models (FMs) offer promising capabilities, their clinical translation for multi-disease detection remains limited by issues such as imbalanced data distribution, uncertainty in multi-label predictions, inter-disease confusion, and domain shifts. Here, we introduce RetExpert, a test-time clinically adaptive framework that enhances FMs for robust and generalizable detection of multiple fundus diseases from color fundus photographs. RetExpert incorporates adaptive knowledge units with a novel stochastic one-hot activation module to improve generalizability, alongside long-tail-aware learning and an uncertainty-aware multi-label learning strategies. It also integrates a fundus disease co-occurrence matrix as medical prior knowledge to mitigate the confusion score (C-score) between diseases. Furthermore, RetExpert employs a lightweight test-time adaptation method combining unsupervised and pseudo-supervised learning (TTUL + TTPL), enabling dynamic parameter adjustment without full retraining. Extensive evaluations on 15 public and private datasets demonstrate that RetExpert outperforms ophthalmic FMs in detection performance, reliability, and cross-domain adaptability, offering a clinically viable solution for automated multi-disease screening in real-world settings.

Identifiers

PMID41772178
PMCPMC13065778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.